Phytomenadione (DrugBank: Phytomenadione)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
288 | 自己免疫性後天性凝固因子欠乏症[自己免疫性出血病XIII (~2017.3)] | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03782025 (ClinicalTrials.gov) | February 13, 2019 | 18/12/2018 | Effect of Vitamin K in Critically Ill Patients | Effect of Vitamin K in Critically Ill Patients With Spontaneously Increased Pro-thrombin Time Measured With Routine Coagulation Tests and Advanced Coagulation- and Vitamin K-assays | Coagulation Factor Deficiency;Coagulopathy, Consumption;Vitamin K Deficiency | Drug: Phytomenadione | Region Skane | NULL | Completed | 18 Years | N/A | All | 51 | Sweden |